Targeted isolation of panels of diverse human protective broadly neutralizing antibodies against SARS-like viruses.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
08 Feb 2022
Historique:
entrez: 16 2 2022
pubmed: 17 2 2022
medline: 17 2 2022
Statut: epublish

Résumé

The emergence of current SARS-CoV-2 variants of concern (VOCs) and potential future spillovers of SARS-like coronaviruses into humans pose a major threat to human health and the global economy

Identifiants

pubmed: 35169804
doi: 10.1101/2021.09.08.459480
pmc: PMC8845431
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : UM1 AI144462
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI157155
Pays : United States
Organisme : NIAID NIH HHS
ID : R61 AI161818
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI145372
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI036214
Pays : United States
Organisme : Bill & Melinda Gates Foundation
ID : INV-004923
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007384
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI149644
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

Immunity. 2015 Nov 17;43(5):959-73
pubmed: 26588781
Nat Med. 2021 Jul;27(7):1205-1211
pubmed: 34002089
N Engl J Med. 2021 Oct 7;385(15):1401-1406
pubmed: 34407341
N Engl J Med. 2021 Apr 8;384(14):1372-1374
pubmed: 33691060
J Struct Biol. 2005 Jul;151(1):41-60
pubmed: 15890530
Science. 2020 Aug 7;369(6504):643-650
pubmed: 32540902
J Virol. 2005 Dec;79(23):14909-22
pubmed: 16282490
Nature. 2020 Aug;584(7821):437-442
pubmed: 32555388
Science. 2020 Aug 28;369(6507):1119-1123
pubmed: 32661058
Science. 2021 Aug 27;373(6558):991-998
pubmed: 34214046
Science. 2021 Aug 13;373(6556):818-823
pubmed: 34016740
Cell Host Microbe. 2020 May 13;27(5):695-698
pubmed: 32407707
Science. 2013 May 10;340(6133):711-6
pubmed: 23539181
Nature. 2022 Mar;603(7903):919-925
pubmed: 35090164
Bioinformatics. 2007 Nov 1;23(21):2947-8
pubmed: 17846036
Immunity. 2021 Aug 10;54(8):1853-1868.e7
pubmed: 34331873
Cell. 2020 Nov 12;183(4):1070-1085.e12
pubmed: 33031744
Cell. 2021 Aug 5;184(16):4203-4219.e32
pubmed: 34242577
J Immunol. 2001 Jan 1;166(1):690-6
pubmed: 11123354
Cell. 2020 Nov 25;183(5):1367-1382.e17
pubmed: 33160446
Sci Transl Med. 2022 Feb 16;14(632):eabi5735
pubmed: 34914540
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
N Engl J Med. 2021 Jul 8;385(2):187-189
pubmed: 33951357
Nature. 2020 Jul;583(7815):290-295
pubmed: 32422645
Nat Rev Microbiol. 2021 Jul;19(7):409-424
pubmed: 34075212
Sci Immunol. 2022 Feb 18;7(68):eabn8014
pubmed: 35076258
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Nat Med. 2021 Apr;27(4):622-625
pubmed: 33654292
JAMA. 2021 Apr 13;325(14):1467-1469
pubmed: 33646292
N Engl J Med. 2020 Nov 12;383(20):1920-1931
pubmed: 32663912
Science. 2021 Feb 12;371(6530):735-741
pubmed: 33436524
J Struct Biol. 2009 May;166(2):205-13
pubmed: 19374019
Science. 2021 Apr 30;:
pubmed: 33931567
Science. 2021 Feb 19;371(6531):759
pubmed: 33602830
Science. 2021 Feb 19;371(6531):823-829
pubmed: 33495307
Science. 2020 Aug 7;369(6504):731-736
pubmed: 32540900
Sci Immunol. 2021 Feb 23;6(56):
pubmed: 33622975
Nature. 2021 Aug;596(7870):109-113
pubmed: 34182569
Nature. 2021 Sep;597(7874):97-102
pubmed: 34261126
Nature. 2021 Sep;597(7874):103-108
pubmed: 34280951
Cell Host Microbe. 2021 Apr 14;29(4):516-521.e3
pubmed: 33798491
Annu Rev Immunol. 2016 May 20;34:635-59
pubmed: 27168247
Nature. 2019 Feb;566(7744):398-402
pubmed: 30760926
PeerJ. 2020 Feb 26;8:e8584
pubmed: 32149022
Immunity. 2018 Aug 21;49(2):301-311.e5
pubmed: 30076101
PLoS Med. 2006 Jul;3(7):e237
pubmed: 16796401
Sci Transl Med. 2022 Aug 10;14(657):eabl9605
pubmed: 35947674
PLoS One. 2015 Jun 26;10(6):e0131451
pubmed: 26115403
J Virol. 2015 Oct 14;90(1):76-91
pubmed: 26468542
Cell Rep. 2021 Sep 28;36(13):109760
pubmed: 34534459
Nat Immunol. 2020 Feb;21(2):199-209
pubmed: 31959979
Viruses. 2021 Apr 07;13(4):
pubmed: 33916927
Sci Transl Med. 2022 Jan 26;14(629):eabj7125
pubmed: 34726473
Science. 2020 Aug 21;369(6506):956-963
pubmed: 32540903
Nat Microbiol. 2020 Apr;5(4):562-569
pubmed: 32094589
Science. 2022 Jan 07;375(6576):43-50
pubmed: 34812653
Immunity. 2020 Dec 15;53(6):1272-1280.e5
pubmed: 33242394
Science. 2021 Sep 03;373(6559):1109-1116
pubmed: 34344823
Nature. 2021 Jun;594(7864):553-559
pubmed: 33971664
Cell Rep. 2022 Feb 1;38(5):110318
pubmed: 35090597
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Nature. 2021 Apr;592(7855):616-622
pubmed: 33567448
J Immunol Methods. 2008 Jan 1;329(1-2):112-24
pubmed: 17996249
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3048-53
pubmed: 26976607
Cell Rep. 2022 Mar 22;38(12):110561
pubmed: 35303475
Nature. 2021 Dec;600(7889):512-516
pubmed: 34544114
J Immunol. 2017 Nov 1;199(9):3369-3380
pubmed: 28978691
Immunity. 2018 May 15;48(5):855-871
pubmed: 29768174
N Engl J Med. 2021 May 20;384(20):1959-1961
pubmed: 33755375
Nature. 2021 Feb;590(7846):386-388
pubmed: 33558746
N Engl J Med. 2021 Aug 12;385(7):585-594
pubmed: 34289274
Nat Med. 2015 Dec;21(12):1508-13
pubmed: 26552008
Sci Immunol. 2021 Dec 10;6(66):eabl5842
pubmed: 34648356
Science. 2019 Dec 6;366(6470):
pubmed: 31672916
Nature. 2020 Dec;588(7839):682-687
pubmed: 33045718
Cell Rep. 2021 Jul 13;36(2):109353
pubmed: 34237283
Nature. 2019 Feb;566(7744):393-397
pubmed: 30664748
Nat Commun. 2019 Feb 7;10(1):628
pubmed: 30733445
Cell. 2020 Aug 20;182(4):828-842.e16
pubmed: 32645326
JAMA. 2021 Apr 6;325(13):1261-1262
pubmed: 33571363
Vaccine. 2021 Jul 22;39(32):4423-4428
pubmed: 34210573
Science. 2021 Mar 25;:
pubmed: 33766944
Curr Opin Immunol. 2018 Aug;53:143-151
pubmed: 29775847
Nature. 2021 Jul;595(7867):426-431
pubmed: 34126625
Nat Struct Mol Biol. 2016 Jan;23(1):81-90
pubmed: 26689967
Sci Immunol. 2021 Apr 15;6(58):
pubmed: 33858945
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Nature. 2021 May;593(7857):130-135
pubmed: 33684923
Nat Commun. 2021 May 19;12(1):2938
pubmed: 34011939
Cell Host Microbe. 2021 Jul 14;29(7):1137-1150.e6
pubmed: 34133950
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701

Auteurs

Wan-Ting He (WT)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.

Rami Musharrafieh (R)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.

Ge Song (G)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.

Katharina Dueker (K)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.

Longping V Tse (LV)

Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

David R Martinez (DR)

Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Alexandra Schäfer (A)

Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Sean Callaghan (S)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.

Peter Yong (P)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.

Nathan Beutler (N)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Jonathan L Torres (JL)

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Reid M Volk (RM)

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Panpan Zhou (P)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.

Meng Yuan (M)

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Hejun Liu (H)

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Fabio Anzanello (F)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.

Tazio Capozzola (T)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.

Mara Parren (M)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Elijah Garcia (E)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Stephen A Rawlings (SA)

Division of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, CA 92037, USA.

Davey M Smith (DM)

Division of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, CA 92037, USA.

Ian A Wilson (IA)

IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.
Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 9203.

Yana Safonova (Y)

Department of Computer Science, Johns Hopkins University, Baltimore, MD 21218, USA.

Andrew B Ward (AB)

IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.
Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Thomas F Rogers (TF)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Division of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, CA 92037, USA.

Ralph S Baric (RS)

Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Departments of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Lisa E Gralinski (LE)

Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Dennis R Burton (DR)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.
Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA 02139, USA.

Raiees Andrabi (R)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.
IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.
Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA.

Classifications MeSH